Your Article Summary
Pharma struggles to adapt as patents expire
Corporate News Releases - The Healthcare Sales & Marketing Network, 11/17/08
New threats to drug makers' revenues are rising even as the industry maneuvers to plug huge holes from looming patent expirations. A newly elected U.S. administration under President-elect Barack Obama brings concerns over pricing and further potential scrutiny, at a time when drug companies have already faced increased uncertainty from the regulators of their products.
Today in Regulatory Issues...keeping you current
Receive free subspecialty "5-minute updates" via email
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Retigabine Regulatory Update
GlaxoSmithKline, 11/03/09
Beware of Tight 5010 Deadline
HealthDataManagement, 10/16/09
Article Search
Sponsor


See Latest Articles


